Condition 1: uveitis. Condition 2: cystoid macular edama. Iridocyclitis, Disorders of iris and ciliary body in diseases classified elsewhere, Posterior cyclitis Degeneration of macula and posterior pole, Other specified retinal disorders
Conditions
Interventions
Intravitreal injection of 500 µg diclofenac- single dose.
Treatment - Drugs
Intravitreal injection of 500 µg diclofenac- single dose
Sponsors
Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: CME resistant to treatment in one or both eyes; Full control of intraocular inflammation; Visual aquity between 20/50 and 5/200; No intraocular or periocular injection during the last 6 month; No previous history of glaucoma or ocular hypertension; No history of previous ocular surgery. Exclusion criteria: Monocular patient; Patients with significant media opacity; Other diseases of the retina with macular involvement; Pregnancy; Drug hypersensitivity to diclofenac.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Aquity. Timepoint: Before, one week and 4 week after intervention. Method of measurement: Snelen Chart- Log MAR.;Central Macular Thickness. Timepoint: Before, one week and 4 week after intervention. Method of measurement: OCT. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intra Ocular Pressure. Timepoint: Before, one week and 4 week after intervention. Method of measurement: Goldman tonometer, mmHg.;Lens opacity. Timepoint: Before, one week and 4 week after intervention. Method of measurement: Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbdolreza Rezaeian Ramsheh
Isfahan University of Medical Sciences
Outcome results
None listed